Header Logo

Connection

KAREN RABIN to Arabinonucleosides

Back to Details
This is a "connection" page, showing publications KAREN RABIN has written about Arabinonucleosides.
KAREN RABIN
Connection Strength
0.045
Arabinonucleosides
  1. Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia. J Clin Oncol. 2020 10 01; 38(28):3282-3293.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.